CUMYL-PEGACLONE

CUMYL-PEGACLONE
Names: CUMYL-PEGACLONE 5-pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one SGT-151
Structure: CAS Number: 2160555-55-3 / InChI : InChI=1S/C25H28N2O/c1-4-5-11-17-26-21-15-10-9-14-20(21)23-22(26)16-18-27(24(23)28)25(2,3)19-12-7-6-8-13-19/h6-10,12-16,18H,4-5,11,17H2,1-3H3/CUMYL-PEGACLONE (SGT-151) is a gamma-carboline based synthetic cannabinoid that has been sold as a designerdrug. The gamma-carboline core structure seen inCUMYL-PEGACLONE had not previously been encountered ina designer cannabinoid, though it is similar in structure to othergamma-carboline cannabinoids disclosed by
Bristol-Myers Squibb in 2001.

CUMYL-PEGACLONE, also known as SGT-151, is a synthetic cannabinoid that has been sold as a designer drug. Its chemical name is 5-pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one12. Here are some key points about CUMYL-PEGACLONE:

Structure: The gamma-carboline core structure in CUMYL-PEGACLONE had not been previously encountered in a designer cannabinoid, although it is structurally similar to other gamma-carboline cannabinoids disclosed by Bristol-Myers Squibb in 20011.
Legal Status:
In Sweden, CUMYL-PEGACLONE is classified as a narcotic substance.
In the United States, the DEA temporarily placed CUMYL-PEGACLONE into Schedule I status starting on December 12th, 2023, for up to 2 years. There’s a possibility that the DEA could file for permanent scheduling within those 2 years. If not, the temporary Schedule I order will expire on December 12th, 2025.
Mode of Action: CUMYL-PEGACLONE is a synthetic cannabinoid receptor agonist with a mode of action suggesting the likelihood of dependence and abuse, similar to other synthetic cannabinoids2.
Remember that CUMYL-PEGACLONE is a potent compound with potential risks, and its use should be approached with caution. Always prioritize safety and adhere to legal regulations when dealing with such substances.